Otsuka 

$20.77
7
+$1.77+9.29% Monday 20:00

Statistics

Day High
19
Day Low
19
52W High
23.04
52W Low
19
Volume
1,000
Avg. Volume
43
Mkt Cap
7.89B
P/E Ratio
26.69
Dividend Yield
1.52%
Dividend
0.32

Upcoming

Dividends

1.52%Dividend Yield
Mar 26
$0.29
Sep 25
$0.31
Mar 25
$0.03
Mar 25
$0.48
Mar 24
$0.48
10Y Growth
5.62%
5Y Growth
10.56%
3Y Growth
12.07%
1Y Growth
5.56%

Earnings

5MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
0.15
0.22
0.29
0.35
Expected EPS
0.21820894857960002
Actual EPS
N/A

Financials

4.81%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
14.61BRevenue
702.99MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OSUKF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Roche
RHHBY
Mkt Cap258.9B
Roche operates in similar pharmaceutical and diagnostics segments, competing directly in the development of innovative drugs and health solutions.
Pfizer
PFE
Mkt Cap140.15B
Pfizer competes in the pharmaceutical sector, offering a wide range of products that overlap with Otsuka's portfolio, including mental health medications.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson's broad healthcare portfolio, including pharmaceuticals and medical devices, positions it as a competitor across several of Otsuka's business areas.
Novartis
NVS
Mkt Cap237.61B
Novartis competes in pharmaceuticals and healthcare, offering products in areas like neurology and psychiatry, directly competing with Otsuka's offerings.
Merck
MRK
Mkt Cap214.76B
Merck operates in the pharmaceutical industry, competing with Otsuka in areas such as healthcare solutions and drug development.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie, with its strong presence in the pharmaceuticals sector, competes in areas of mutual interest like neuroscience and oncology.
Takeda Pharmaceutical
TAK
Mkt Cap42.62B
Takeda Pharmaceutical Company has a significant overlap with Otsuka in the pharmaceutical sector, especially in Japan, competing in similar therapeutic areas.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline competes with Otsuka in the pharmaceutical and healthcare sectors, including areas like mental health.
Sanofi
SNY
Mkt Cap124.45B
Sanofi operates globally in the pharmaceutical sector, competing with Otsuka in various therapeutic areas, including mental health and neurology.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a global competitor in the pharmaceutical industry, with a product range that competes with Otsuka's, especially in the oncology and neurology segments.

About

Otsuka Corporation, together with its subsidiaries, operates as an information technology (IT) platformer in Japan. It operates through System Integration Business, and Service and Support Business segments. The System Integration Business segment offers management systems and collaborative software, such as ERP packages and groupware to cover a range of specialized fields, including CAD and web technologies; and software, hardware, intranet, and security products for the construction and expansion of computer networks, as well as intermediary services between manufacturers and system integrators. This segment also sells computers, copiers, and communications equipment; develops consigned software; and develops and sells packaged software. The Service and Support Business segment is involved in the provision of emergency computer rescue services for corporate and individual clients; coordination of multi-vendor efforts consisting of pick-up, repair, and return of computers. It also offers 24/7 network support and services for the planning, design, construction, and operation of corporate information systems; and educational support services, as well as out-sources system engineers. Otsuka Corporation was founded in 1961 and is headquartered in Tokyo, Japan.
Show more...
CEO
Mr. Yuji Otsuka
Employees
9680
Country
JP
ISIN
JP3188200004

Listings

0 Comments

Share your thoughts

FAQ

What is Otsuka stock price today?
The current price of OSUKF is $20.77 USD — it has increased by +9.29% in the past 24 hours. Watch Otsuka stock price performance more closely on the chart.
What is Otsuka stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Otsuka stocks are traded under the ticker OSUKF.
What is Otsuka market cap?
Today Otsuka has the market capitalization of 7.89B
When is the next Otsuka earnings date?
Otsuka is going to release the next earnings report on May 05, 2026.
What were Otsuka earnings last quarter?
OSUKF earnings for the last quarter are 0.3 USD per share, whereas the estimation was 0.29 USD resulting in a +4.19% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Otsuka revenue for the last year?
Otsuka revenue for the last year amounts to 14.61B USD.
What is Otsuka net income for the last year?
OSUKF net income for the last year is 702.99M USD.
Does Otsuka pay dividends?
Yes, OSUKF dividends are paid semi-annual. The last dividend per share was 0.29 USD. As of today, Dividend Yield (FWD)% is 1.52%.
How many employees does Otsuka have?
As of April 02, 2026, the company has 9,680 employees.
In which sector is Otsuka located?
Otsuka operates in the Information Technology sector.
When did Otsuka complete a stock split?
The last stock split for Otsuka was on March 28, 2024 with a ratio of 2:1.
Where is Otsuka headquartered?
Otsuka is headquartered in Tokyo, JP.